Archive for the ‘Cancer / Oncology’ Category

Removal Of Superficial Tumours In Oesophagus By Endoscopy Can Avoid Complete Extirpation Of This Part Of The Digestive Tract

Sunday, April 13th, 2008

The removal through endoscopy of tumours that affect only the superficial layers of the oesophagus can avoid complete extirpation of this part of the digestive tract. The technique, carried out at the University Hospital of Navarra for the last three years, was presented at the VI International Course on Therapeutic ...

New Class Of Anti-Cancer Drugs That Target PI 3-kinase In Clinical Trials

Sunday, April 13th, 2008

The Institute of Cancer Research announces that a drug candidate, first identified during a research collaboration with UK biotechnology company Piramed Limited, is in clinical development. The trials are currently underway in the UK at The Institute of Cancer Research, The Royal Marsden NHS Foundation Trust and in the U.S. ...

Overall Decrease In Kidney Cancer Deaths In Europe

Sunday, April 13th, 2008

Overall deaths from kidney cancer have now fallen across Europe after peaking in the early 1990s, according to a detailed analysis of mortality rates for 32 countries published in the urology journal BJU International.The review is based on official death records collated by the World Health Organization from 1984 to ...

Joining Forces: European Society For Medical Oncology And European CanCer Organization

Saturday, April 12th, 2008

The European Society for Medical Oncology (ESMO) and ECCO - the European CanCer Organisation have united forces to host a co-branded biennial multidisciplinary partnership meeting that will provide the best and most updated scientific data for everyone working in cancer and will also strengthen initiatives aimed at providing all cancer ...

EntreMed To Highlight ENMD-2076 Kinase Inhibitor At 2008 AACR Annual Meeting

Saturday, April 12th, 2008

EntreMed, Inc. (Nasdaq: ENMD), a clinical-stage pharmaceutical company developing therapeutics for the treatment of cancer and inflammatory diseases, announced it will present preclinical data for its product candidates ENMD-2076, MKC-1, and ENMD-1198. The data will be presented by EntreMed scientists and collaborators during the American Association for ...

Solarium Ban For Under-18s And Fair-skinned People, New South Wales, Australia

Saturday, April 12th, 2008

As from January, 2009, people with fair skin and those under the age of 18 will not be allowed to use solariums in New South Wales (NSW), Australia, the NSW Government has announced. The NSW Government stressed that this legislation will become enforceable on January 1st, regardless of what ...

New Pan-European Collaboration Launched Into The Diagnosis And Control Of Coeliac Disease

Friday, April 11th, 2008

12 million euros, equivalent to nearly 9.5 million pounds has been invested by the European Commission into a new pan-European partnership which will design an advanced diagnostic tool for the detection and control of coeliac disease, the most under-diagnosed common chronic condition in the UK today.The collaborative project, entitled Coeliac ...

Research Presented At ISHLT Shows Promise Of Addressing Critical Organ Shortage

Friday, April 11th, 2008

Data from experimental work on the use of organs from cardiac arrested donors is being presented this week at the International Society for Heart and Lung Transplantation's 28th Annual Meeting and Scientific Sessions. Utilizing donors after cardiac death (DCD), also known as non-heart-beating donors (NHBDs) has the potential to overcome ...

Extending Life By Tackling Depression In Cancer Patients

Friday, April 11th, 2008

A study recommended by David Spiegel of Faculty of 1000 Medicine (http://www.f1000medicine.com/), looks at the relationship between depression care management and survival rates in older patients. He identifies it as "an important and well-conducted study of the effects of treatment of depression on survival in a primary care setting"A leading ...

Kalos Therapeutics Data Confirming Anti-Cancer Effect Of Naturally Occurring Heart Hormones Presented At Experimental Biology 2008 Symposium

Friday, April 11th, 2008

Kalos Therapeutics, a privately held biopharmaceutical company developing the Atrial Natriuretic Peptide (ANP) family for the treatment of human cancers, announced that David L. Vesely, M.D.,Ph.D., (University of South Florida) presented additional positive xenograft data today at the Experimental Biology 2008 Symposium on Heart Hormones. The data confirmed and expanded ...